Jinwon Jung

ADCs,CGT, RNA and degraders under pressure to prove safety, scale, and staying power Pharma’s buzziest modalities met a reality check in Seoul. At Korea Biomedical Review’s 4th K-Healthcare Business Forum held Tuesday at POSCO Tower Yeoksam, a half-day program on “Exploring New Modali...

www.koreabiomed.com/news/article...

25.09.2025 08:06 — 👍 1    🔁 0    💬 0    📌 0

[약업신문]에이비엘바이오, 또 한번 밸류업㊤…이중항체 ADC 2건 임상 진입 확실시 에이비엘바이오 정진원 이사.©약업신문에이비엘바이오가 내년 또 한 번 밸류업 실현을 예고했다. 이중항체 기반 ADC(항체약물접합체) 신약후보 물질 두 건이 임상에 진입할 것이 확실시되고 있다.에이비엘바이오...

m.yakup.com/news/index.h...

11.06.2025 07:59 — 👍 0    🔁 0    💬 0    📌 0

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer AbstractPurpose:. Antibody–drug conjugates (ADC) harboring topoisomerase I (TOP1) inhibitor payloads have improved survival for patients with metastatic breast cancer. However, knowledge of ADC resist...

aacrjournals.org/clincancerre...

09.04.2025 08:37 — 👍 0    🔁 0    💬 0    📌 0

TOP1 Priority: Advancing Biomarker-Driven Patient Selection for the Use of ADCs Summary. A recent study reports the emergence of TOP1 mutations as a potential mechanism of resistance to topoisomerase inhibitor antibody–drug conjugates (ADC) in advanced breast cancer. This is a cr...

aacrjournals.org/clincancerre...

09.04.2025 08:37 — 👍 0    🔁 0    💬 0    📌 0

Kimchi stew with rice and radish kimchi

Saturday vibes!

22.03.2025 21:35 — 👍 32    🔁 2    💬 1    📌 0

김치찌개? Awesome!

23.03.2025 03:12 — 👍 1    🔁 0    💬 0    📌 0

The University of Pittsburgh pauses its Ph.D. admissions process amid research funding uncertainty A spokesperson for the University told WESA Friday that the school has "temporarily paused additional Ph.D. offers of admission," while Pitt works to understand how proposed federal funding cuts could...

The University of Pittsburgh confirmed Friday that there would be no new Ph.D. offers of admission while Pitt works to understand how reduced federal aid could impact the institution.

21.02.2025 21:56 — 👍 1198    🔁 773    💬 55    📌 350

내 논문 리비전도 못하고 있는데 남의 논문 리뷰를 해야하네.

25.01.2025 00:43 — 👍 0    🔁 0    💬 0    📌 0

I-Mab Prioritizes Givastomig Cancer Drug Program, Reports $184M Cash Runway Through 2027 I-Mab completes enrollment for givastomig combination therapy study in gastric cancer, showing promising safety profile. Phase 1 results demonstrate 16.3% response rate in monotherapy.

#IMAB I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

https://www.stocktitan.net/news/IMAB/i-mab-announces-portfolio-prioritization-of-givastomig-cldn18-2-x-4-9wcakjaviuei.html

06.01.2025 12:00 — 👍 0    🔁 1    💬 0    📌 0

Vaccines are being attacked left and right BECAUSE they work so well that people have conveniently forgotten about polio and poxes.

Here is a contemporary example in oncology. Vaccines prevent cancer and reduce cancer deaths - do you know how hard THAT is??

Spread the words - vaccine save lives!

30.11.2024 14:24 — 👍 15    🔁 8    💬 0    📌 1

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination.

ja.ma/4i9ghPC

28.11.2024 00:37 — 👍 2067    🔁 617    💬 32    📌 104